Finished CDE packaging material filling
Authorized 9 patents, 1 PCT, passed FTO in China and India.
Compatible with 3ml cartridge with standard ISO 13926
Conforms to ISO11608:2022
Areas of Care:
Diabetes-insulin /GLP-1 Semaglutide® ( Ozempic® , Wegovy® similar)
Liraglutide®( Saxenda® ,Victoza® similar)
Tirzepatide® treatment ( Mounjaro ® similar)
Injector Model | HL001 | HL008 |
Primary Container | 3ml cartridge | 3ml cartridge |
Injection Dose | Adjustable | Adjustable |
Viscosity | ≤5cP | ≤5cP |
Needle Diameter | 31G/32G or smaller | 31G/32G or smaller |
Manual & Auto | Auto | Auto |
Minimum Adjustable Single Dose | 0.01ml | 0.01ml |
Maximum Adjustable Single Dose | 0.75ml | 0.74ml/0.75ml/0.8ml |
Injection Time | Single injection time 6 seconds or less | Single injection time 6 seconds or less |
Injection Precision | ±2% | ±2% |
Feedback after Injection Completed | Visual and Auditory | Visual and Auditory |
Dimensions | φ19.5*161mm | φ19.5*161mm |
Maggic is a user-friendly multi-dose pen injector for insulin and GLP-1, with advanced features and customizable options. It's designed for ease of use, precision, and compatibility with standard cartridges.
The Reusable Pen Injector has a 3ml capacity, doses up to 0.6ml in 0.01ml increments, and uses a push mechanism, aligning with the standard features of reusable pens.
The Imogen/Honor/Grow autoinjectors offer 1mL and 2.25mL options for pre-filled syringes, with a simple, single-dose operation and ergonomic design.